Brief: Microba Life Sciences Says 1H Unaudited Revenue Totalled A$3.27M
30/01/2024 24:59
Jan 30 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* 1H FY24 UNAUDITED REVENUE TOTALLED A$3.27M, UP 52%
Source text for Eikon: ID:nASX9wttkV
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement